Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Gracell Biotechnologies Doses First Patient in Phase 2 Portion of Registrational Phase 1/2 Clinical Trial Evaluating GC007g for Treatment of B-cell Acute Lymphoblastic Leukemia 2022-10-17 20:05
PharmAbcine Announces Poster Presentations on Its anti-VISTA Antibody Candidate at SITC 2022 2022-10-17 20:00
PENTAX Medical launches the C2 CryoBalloon(TM) Ablation System in Canada for the treatment of Barrett's Esophagus. 2022-10-15 03:57
Tianfu International Biocity: Build Global Bioindustry-city 2022-10-14 20:48
Fosun Pharma's MSCI ESG Rating Upgraded to A 2022-10-14 08:26
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia for the Treatment of Individuals with Multiple System Atrophy 2022-10-13 22:25
First in North America: Jolly Good Hosts Clinical VR Multi Seminar in Boston, Aiming for Mass Production of UGC Medical VR 2022-10-13 21:00
Research Collaboration between Prof. Antonio Gasbarrini team at Gemelli Hospital and Asian Biotech companies, Coree and Dx&Vx 2022-10-13 21:00
Neurophth Therapeutics Conducts Special Interview with Dr. Satoshi Kashii on World Sight Day 2022-10-13 20:30
Harbour BioMed Announces Upcoming Poster Presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting 2022-10-13 19:05
Samsung Biologics obtains three global ISO certifications 2022-10-13 19:00
Guiyang's Wudang district shines in pharma sector 2022-10-13 10:12
United Imaging Ships Global Installations Number 20,000, 20,001 and 20,002 from its Houston Headquarters to New York City 2022-10-12 21:00
Great Bay Bio Announces Official Launch of Site-Specific Integration Platform for Cell Line Development, AlfaCell® 2022-10-11 20:40
HanAll's Licensed Partner in China Enters Sublicense Agreement with CSPC to Further Accelerate Development of Batoclimab 2022-10-11 19:00
Samsung Biologics unlocks additional capacity for production at its newest Plant 4 2022-10-11 19:00
IASO Biotherapeutics and Cabaletta Bio Announce Exclusive Worldwide License Agreement for Clinically Validated CD19 Binder 2022-10-11 19:00
Actinogen Medical Limited (ACW) announces large Xanamem® therapeutic effect in early-stage Alzheimer's Disease (AD) patients 2022-10-10 20:00
Hugel resubmits BLA for its botulinum toxin, Botulax to the U.S. FDA 2022-10-08 11:00
Antengene Announces Upcoming Presentations at the 2022 Society for Immunotherapy of Cancer Annual Meeting 2022-10-08 10:43
1 109 110 111 112 113 432